AHEALTH | APEX HEALTHCARE BERHAD
3.15 (-2.48%)
T-O: 3.2 (08:59:00)
Last updated: 10:10
iSaham Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
Quarter Reports
Trailing Dividend
Financial Ratios
| EPS | 15.5 sen |
| Trailing PE (Sector Median: 16.9) | 20.3 |
| PEG | 0.2 |
| Altman Z | 2.8 |
| Beaver | 0.131 |
| Current Ratio | 2.77 |
| Debt-Equity (DE) Ratio | 0.34 |
| FCF Yield | -0.11 % |
| Revenue QoQ | 14.62 % |
| Revenue YoY | 20.38 % |
| Profit QoQ | 83.15 % |
| Profit YoY | 38.73 % |
| Profit Margin (Sector Median: 7.2) | 8.87 % |
| ROE (ROIC: 14.46) | 14.65 % |
| Dividend Per Share (DPS) | 12.0 sen |
| Dividend Yield (DY) | 3.82 % |
Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 3 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 1.06 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 23.49 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 250.22 |
| Expected Revenue (M) | 3199.73 |
| Expected Growth (%) | 26.0 |
Directors Share Purchases (Beta)
MR KEE KIRK CHUEN added 30000.0 units announced on 14 Jul 2022 at ~RM2.92
MR ROBERT DOBSON MILLNER added 44000.0 units announced on 12 Jul 2022 at ~RM2.92
DR KEE KIRK CHIN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92
MR KEE KIRK CHUEN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92
MR ROBERT DOBSON MILLNER added 76000.0 units announced on 08 Jul 2022 at ~RM2.9
MR ROBERT DOBSON MILLNER added 80000.0 units announced on 07 Jul 2022 at ~RM2.85
MR KEE KIRK CHUEN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55
DR KEE KIRK CHIN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55
MR KEE KIRK CHUEN added 30000.0 units announced on 13 Dec 2021 at ~RM2.57
DR KEE KIRK CHIN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9
MR KEE KIRK CHUEN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9
MR KEE KIRK CHUEN added 74000.0 units announced on 25 May 2021 at ~RM2.89
DR KEE KIRK CHIN added 74000.0 units announced on 25 May 2021 at ~RM2.89
DR KEE KIRK CHIN added 58000.0 units announced on 24 May 2021 at ~RM2.83
MR KEE KIRK CHUEN added 58000.0 units announced on 24 May 2021 at ~RM2.83
MR KEE KIRK CHUEN added 50000.0 units announced on 12 Mar 2021 at ~RM2.87
MR KEE KIRK CHUEN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35
DR KEE KIRK CHIN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35
Summary
Market Cap: 1498 M.
Number of Shares: 477 M.
Adjusted Float: 30.3%.
Stock highly correlated with
LKL (82%)
JIANKUN (80%)
PASUKGB (80%)
G3 (79%)
Apex Healthcare Berhad is an investment holding company. The company is engaged in the development, manufacturing, wholesaling, marketing, and distribution of pharmaceuticals, consumer healthcare products, and medical devices. For example range of products in the manufacturing segment include cough mixtures and antihistamines, anti-infectives, anti-diabetics, anti-hypertensives, neuromuscular agents, analgesics, dermatological and ophthalmological in the form of tablets, capsules, oral liquid, and suspension, creams, and sterile eyedrops. The company is also one of the distributors for internationally famous brands such as Nestle, 3M, and Rigel Pharma. It has direct operations in Malaysia, Singapore, Vietnam, and Myanmar. The company was founded in 1962 and is headquartered in Melaka, Malaysia.
Sectors: Pharmaceuticals, Healthcare, Vaccine
Code: 7090
Website: http://www.apexhealthcare.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
Top Shareholdings
Updated on 15-Mar-2022
| Shareholder | Value (M) |
|---|---|
| Apex Pharmacy Holdings Sendirian Berhad | 599.36 |
| Washington H.Soul Pattinson and Company Limited | 446.79 |
| Lim Teh Realty Sdn Berhad | 20.4 |
| Md Ali Bin Md Dewal | 15.45 |
| Liew Yoon Yee | 13.2 |
| Xepa Holdings Sdn. Bhd. | 13.05 |
| Public Islamic Opportunities Fund | 12.6 |
| Tan Yan Meng Warren | 12.6 |
| DBS Bank Ltd | 12.0 |
| Apex Holdings (Pte) Ltd | 8.1 |
| Employees Provident Fund Board | 8.1 |
| Chan Heng Koon | 7.8 |
| Teoh Choon Neo @ Ivy Teoh Choon Neo | 7.2 |
| Public Focus Select Fund | 7.2 |
| Manulife Investment Progress Fund | 7.05 |
| Singam A/L Kumarasamy | 6.9 |
| PB Islamic Smallcap Fund | 6.6 |
| ICapital.Biz Berhad | 6.45 |
| Yeo Lee Hee | 5.85 |
| Rastam Dewal Bin Md Ali | 5.7 |
| Oh Siew Heong | 5.1 |
| Wong Yee Hui | 5.1 |
| Tan Jin Thai | 4.8 |
| Kee Kirk Chin | 4.2 |
| Leong Wai Kuen | 3.9 |
| Susy Ding | 3.9 |
| Phua Kiap Wite | 3.6 |
| Lim Khuan Eng | 3.45 |
Social
